Denominazione Comune Italiana
Denominazione Comune Italiana (DCI)
Denominazione Comune Italiana (DCI) (pronounced: Deh-noh-mee-nah-zee-oh-neh Coh-moo-neh Ee-tah-lee-ah-nah) is the official Italian system for the naming of medicinal products. The term is derived from the Italian language, with "Denominazione" meaning "denomination" or "name", "Comune" meaning "common", and "Italiana" meaning "Italian".
History
The DCI was established by the Italian Medicines Agency (AIFA), the national authority responsible for drug regulation in Italy. It was created to provide a standardized nomenclature for medicinal products, ensuring clarity and avoiding confusion in the pharmaceutical market.
Function
The DCI assigns a unique and official name to each medicinal product. This name is used in all official documents and communications relating to the product. The DCI is similar to the International Nonproprietary Name (INN) system used globally, but it is specific to Italy.
Related Terms
- Medicinal product: Any substance or combination of substances presented for treating or preventing disease in human beings or animals.
- Italian Medicines Agency (AIFA): The national authority responsible for drug regulation in Italy.
- International Nonproprietary Name (INN): The official nonproprietary or generic name given to a pharmaceutical substance, as designated by the World Health Organization (WHO).
See Also
External links
- Medical encyclopedia article on Denominazione Comune Italiana
- Wikipedia's article - Denominazione Comune Italiana
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski